Health

Biocytogen Awarded U.S. Patent for RenLite® Common Light Chain Mouse Platform

BEIJING, June 21, 2024 /PRNewswire/ -- Biocytogen Pharmaceuticals (Beijing) Co., Ltd. ("Biocytogen", HKEX: 02315) announced United States Patent and Trademark Office (USPTO) patent grant for independently developed RenLite® fully human common light chain mouse platform.

2024-06-21 17:45 8438

ISTH announces launch of new global education initiative in factor XI/XIa inhibition

Leading international society embarks on multi-year initiative to increase clinician awareness of factor XI/XIa inhibition BANGKOK, June 21, 2024 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH), the leading worldwide not-for-profit organization dedicated to advanci...

2024-06-21 14:00 2587

ISTH Releases Evidence-Based Clinical Practice Guideline for Hemophilia Treatment

CHAPEL HILL, N.C., June 21, 2024 /PRNewswire/ -- The International Society on Thrombosis and Haemostasis (ISTH), the leading international professional medical-scientific organization dedicated to advancing the understanding, prevention, diagnosis, and treatment of conditions related to thrombosi...

2024-06-21 14:00 1847

Ascentage Pharma Announces Closing of US$75 Million Equity Investment by Takeda

ROCKVILLE, Md. and SUZHOU, China, June 21, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that the agreed equity investment by Takeda has bee...

2024-06-21 09:19 4247

USANA Philippines Joins DSAP as its Newest Official Member

MANILA, Philippines, June 21, 2024 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in global nutrition, is proud to announce that itsPhilippines market has been unanimously approved to become the newest member of the Direct Selling Association ofthe Philippines (DSAP). This is a significant...

2024-06-21 07:07 3366

Tobii launches Tobii Nexus - webcam eye tracking for integration into any device or application

TAIPEI, June 20, 2024 /PRNewswire/ -- A software-only integration platform that enables eye tracking capabilities for devices with a webcam, helping developers create smarter abilities and interactivity within their applications – for any user, on any device. Tobii, the global leader in eye tr...

2024-06-20 18:00 2523

Ping An Receives Five "All-Asia Executive Team 2024" Accolades From Institutional Investor Magazine

HONG KONG and SHANGHAI, June 20, 2024 /PRNewswire/ -- Institutional Investor magazine has announced the ranking of 2024 Asia (ex-Japan) Executive Team. Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An", the "Company" or the "Group", HKEX: 2318 / 82318; SSE: 601318) is delighted...

2024-06-20 12:26 4445

Ping An Announces Brand Upgrade of "Ping An Family Doctor"

HONG KONG and SHANGHAI, June 19, 2024 /PRNewswire/ -- The "Ping An Family Doctor Brand Upgrade Conference" was held inShanghai recently. Ping An Insurance (Group) Company ofChina, Ltd. (hereafter "Ping An" or the "Group", HKEX: 2318 / 82318; SSE: 601318) has upgraded its "Ping An Family Doctor" ...

2024-06-19 18:15 4141

Clarivate Identifies Seven Innovators in Antibody Drug Conjugates in New Companies to Watch Report

Emerging standouts set to transform drug discovery and development, revolutionize cancer treatment, and capture big pharma interest highlighted in third annual report LONDON, June 19, 2024 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has re...

2024-06-19 15:00 1572

Innovent Reports Oncology Pipeline Updates at Investor Meeting

SAN FRANCISCO and SUZHOU, China, June 19, 2024 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune, ophthalmology and o...

2024-06-19 10:55 4327

Menarini Asia-Pacific partners with Pharmacosmos to expand its reach of MonoFer® to Singapore and Malaysia

SINGAPORE, June 19, 2024 /PRNewswire/ -- Menarini Asia-Pacific (Menarini) today announced that it has expanded its partnership with Pharmacosmos A/S (Pharmacosmos), to include exclusive rights to commercialiseMonoFer® (ferric derisomaltose) in Singapore and Malaysia. This builds upon the successf...

2024-06-19 09:43 2205

ZA Tech Rebrands as Peak3, Raises US$35M Series A led by EQT

SINGAPORE, June 19, 2024 /PRNewswire/ -- ZA Tech, the next-generation insurance core system SaaS provider, has rebranded asPeak3 . With the successful completion of itsUS$35 million Series A fundraising from EQT (lead investor) and Alpha JWC Ventures,Peak3 now accelerates i...

2024-06-19 09:00 2740

Micro Medical Solutions Achieves Milestone with 200th Enrollment in HEAL Registry

Clinical investigators complete record enrollment in real-world Registry, HEAL (An All-comers Registry of the MicroStent PeripHeral Vascular StEnt in subjects with PeripherAl ArteriaL Disease) WILMINGTON, Mass., June 19, 2024 /PRNewswire/ -- Micro Medical Solutions -- Micro Medical Solutions, a ...

2024-06-19 07:11 1860

Manulife and World Economic Forum Launch the Prospering in Longevity Challenge to Drive Health and Financial Resiliency

Multi-year partnership taking steps to help shape the future and funding of human longevity innovation  TORONTO, June 18, 2024 /PRNewswire/ -- Manulife and the World Economic Forum ("the Forum"), today announced the launch of the Prospering in Longevity Challenge, through UpLink, the Forum's ope...

2024-06-18 23:23 1931

Prenetics Announces First Quarter 2024 Financial Results

First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter Confirms Strategic Pivot Targeting the U.S. Consumer Healthcare Market  Reaffirms 2024 Revenue Range of US$33 million to US$36 million LOS ANGELES, June 18, 2024 /PRNewswire/ -- Prenetics Global Limit...

2024-06-18 20:30 4015

Clover Announces Positive Preliminary Phase Ⅰ Results for Bivalent RSV Vaccine Candidate SCB-1019 in Older Adults

-- Bivalent SCB-1019 significantly boosted RSV-A and RSV-B neutralizing antibody titers in older adults up to approximately 7,900 IU/mL (up to 8-fold increase) and approximately 46,700 IU/mL (up to 11-fold increase), respectively -- -- Favorable safety & reactogenicity profile comparable to sali...

2024-06-18 17:41 2265

Thermo Fisher Scientific, National University Hospital and Mirxes Collaborate to Enhance Access to Advanced Genomic Testing for Early Cancer Detection in Singapore

Partnership Aims to Personalize Cancer Care Tailored to the Needs of Southeast Asian Population to Provide Better Individualized Care SINGAPORE, June 18, 2024 /PRNewswire/ -- To increase patient access to affordable, advanced genomic testing for cancer inSingapore, Thermo Fisher Scientific Inc.,...

2024-06-18 16:46 5854

Diplomatic Envoys to China Visit Fosun: Appreciating Oriental Lifestyle Aesthetics and Seeking Opportunities for Business Cooperation

SHANGHAI, June 18, 2024 /PRNewswire/ -- Over 40 guests, including 10 ambassadors toChina, 8 consuls general and other senior diplomats from 26 countries, visited Fosun on 14 June. The delegation toured along the Grand Yuyuan. From the intangible cultural heritage of the Old City of Shanghai to t...

2024-06-18 12:53 3577

Live from EHA 2024 | Ascentage Pharma Releases Updated Data of Lisaftoclax in Patients with R/R MM and AL Amyloidosis Highlighting Marked Improvement in ORR

SUZHOU, China and ROCKVILLE, Md., June 18, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that it has released updated data of the Bcl-2 inh...

2024-06-18 12:43 2165

Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including Encouraging Data from US Study in CML and Ph+ ALL

SUZHOU, China and ROCKVILLE, Md., June 18, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis B (CHB), and age-related diseases, announced today that updated results from three studies of olverem...

2024-06-18 12:23 1964
1 ... 43444546474849 ... 580

Week's Top Stories